The use of tobramycin for Pseudomonas aeruginosa: a review-Reference-Cited by-同舟云学术

The use of tobramycin for Pseudomonas aeruginosa: a review

Published:2022-04-04 Issue:5 Volume:16 Page:503-509
ISSN:1747-6348
Container-title:Expert Review of Respiratory Medicine
language:en
Short-container-title:Expert Review of Respiratory Medicine

Author:

Fiel Stanley B.¹,Roesch Erica A.²

Affiliation:

1. Department of Medicine, Morristown Medical Center, Morristown, NJ, USA

2. University Hospitals, Rainbow Babies and Children’s Hospital and Case Western Reserve University, Cleveland, OH, USA

Publisher

Informa UK Limited

Subject

Public Health, Environmental and Occupational Health,Pulmonary and Respiratory Medicine,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/17476348.2022.2057951

Reference44 articles.

1. Cystic fibrosis in adults: an overview for the internist.

2. Cystic Fibrosis Foundation. Patient registry annual data report. Accessed 2021 Jun 7. https://www.cff.org/Research/Researcher-Resources/Patient-Registry/2019-Patient-Registry-Annual-Data-Report.pdf

3. Coexistence with Pseudomonas aeruginosa alters Staphylococcus aureus transcriptome, antibiotic resistance and internalization into epithelial cells

4. Cystic Fibrosis Foundation. Pseudomonas. Available to 2021 Apr 20. https://www.cff.org/Life-With-CF/Daily-Life/Germs-and-Staying-Healthy/What-Are-Germs/Pseudomonas/

5. Factors associated with reduced FEV1 in adult patients with cystic fibrosis in a relatively affluent area

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adherence to inhaled antibiotics in people with cystic fibrosis: insights from a virtual patient advisory board;Expert Review of Respiratory Medicine;2023-10-03

2. Microevolution of Pseudomonas aeruginosa in the airways of people with cystic fibrosis;Current Opinion in Immunology;2023-08

3. Efficacy and Safety of Dry Powder Antibiotics: A Narrative Review;Journal of Clinical Medicine;2023-05-20

4. Drug Combination of Ciprofloxacin and Polymyxin B for the Treatment of Multidrug–Resistant Acinetobacter baumannii Infections: A Drug Pair Limiting the Development of Resistance;Pharmaceutics;2023-02-21

5. Inhibitory Effects of Trans-Cinnamaldehyde Against Pseudomonas aeruginosa Biofilm Formation;Foodborne Pathogens and Disease;2023-02-01